Translating Medical Necessity Criteria for ABA Providers

By: Erin Mayberry
Translating Medical Necessity Criteria for ABA Providers with Erin Mayberry, Diana Davis Wilson

Long-standing research on the effects of ABA services to treat ASD indicates that treatment intensity may greatly influence the response to treatment in children.

As such, clinicians should carefully calibrate and adhere to dosage recommendations.

Studies have concluded that adhering to prescribed treatment dosages, aligned with published research, improves outcome mastery and increases adaptive behavior skills.

Legislative advocacy and policy development efforts in the elimination of managed health plans perceived prescriptive authority over medical necessity determination have been a priority of many clinicians, lawyers and policymakers.

However, understanding the health plan’s role in medical necessity and utilization management, as well as limitations in the ability to conduct well-controlled research on the intensity of treatment recommendation remains a challenge.

Despite best practice standards and available research supporting proper dosage recommendations, the variability in dosage recommendations may still be negatively influenced by a variety of factors.

These include, but are not limited to:

  • A complex language barrier between the clinician and the health plan
  • Lack of clinician training in what is medically necessary
  • Unlawful or otherwise ineffective mandates enforced by funding sources
  • Limitations in applied research 

Prescription fidelity affects both the clinical and operational sides of the effective delivery of autism services.

As the field of Autism Services has continued to grow, the appropriate measures of clinical quality remain embedded in providing the adequate intensity of service on the individual patient level.

The drastic under-prescribing of care, that is industry-wide, affects the ability for patients to receive optimum results.

It also creates additional administrative costs and burdens on autism providers, which results in scaling and fiscal management challenges.

To continue the conversations related to the medical necessity of autism treatment, the development of a medical necessity review tool may lend guidance for clinicians.

This will help them move toward consistency in considerations of medical necessity justification and appropriate dosage.

Registration for this event has closed.

About the Author

Headshot of Erin Mayberry, Director of Community Engagement for RethinkBH

Director of Community Engagement

Erin Mayberry is a Board Certified Behavior Analyst who has been in the field of ABA since 2009. Prior to Rethink, Erin provided clinical consultation to individuals on the autism spectrum and their families in home, clinic, and school settings, as well as staff training in behavioral crisis prevention. Erin has been with Rethink since 2018, and has worked in professional services, customer success, and most recently as Rethink’s Director of Community Engagement, working with our customers to create successful and meaningful partnerships.

Share with your community

Facebook
Twitter
LinkedIn

Sign up for our Newsletter

Subscribe to our monthly newsletter on the latest industry updates, Rethink happenings, and resources galore. Simply follow the link to the footer and enter your email.

Related Resources

Blog

As a BCBA working with different ABA therapy practices, I often see leaders stuck in...

Blog

With summer right around the corner, ABA therapy providers have an exciting opportunity to shake...

Blog

As the summer season approaches, planning effective Applied Behavior Analysis (ABA) programs becomes a priority...